384P Prevalence of fibroblast growth factor receptor 2b (FGFR2b) protein overexpression in squamous non-small cell lung cancer (sqNSCLC).

MLA

Akamatsu, H., et al. “384P Prevalence of Fibroblast Growth Factor Receptor 2b (FGFR2b) Protein Overexpression in Squamous Non-Small Cell Lung Cancer (SqNSCLC).” Annals of Oncology, vol. 33, Nov. 2022, p. S1591. EBSCOhost, https://doi.org/10.1016/j.annonc.2022.10.421.

APA

Akamatsu, H., Yang, J. .-H., Wakuda, K., Hawkins, J., Yanes, R. E., Homann, O., Tan, M., Finger, E., & Borghaei, H. (2022). 384P Prevalence of fibroblast growth factor receptor 2b (FGFR2b) protein overexpression in squamous non-small cell lung cancer (sqNSCLC). Annals of Oncology, 33, S1591. https://doi.org/10.1016/j.annonc.2022.10.421

Chicago

Akamatsu, H., J.C-H. Yang, K. Wakuda, J. Hawkins, R.E. Yanes, O. Homann, M. Tan, E. Finger, and H. Borghaei. 2022. “384P Prevalence of Fibroblast Growth Factor Receptor 2b (FGFR2b) Protein Overexpression in Squamous Non-Small Cell Lung Cancer (SqNSCLC).” Annals of Oncology 33 (November): S1591. doi:10.1016/j.annonc.2022.10.421.